Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

'Staying strong on the inside and outside' to keep walking and moving around: Perspectives from Aboriginal people with Machado Joseph Disease and their families from the Groote Eylandt Archipelago, Australia.

Carr JJ, Lalara J, Lalara G, O'Hare G, Massey L, Kenny N, Pope KE, Clough AR, Lowell A, Barker RN.

PLoS One. 2019 Mar 11;14(3):e0212953. doi: 10.1371/journal.pone.0212953. eCollection 2019.

2.

Safety and efficacy of recovery-promoting drugs for motor function after stroke: A systematic review of randomized controlled trials.

Firth N, Barker RN, Hayward KS, Bernhardt J, Bellingan M, Gunnarsson R.

J Rehabil Med. 2019 May 13;51(5):319-330. doi: 10.2340/16501977-2536.

3.

Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the major human platelet autoantigen glycoprotein IIb/IIIa in HLA-transgenic mice.

Hall LS, Lennon CS, Hall AM, Urbaniak SJ, Vickers MA, Barker RN.

Haematologica. 2019 May;104(5):1074-1082. doi: 10.3324/haematol.2017.179424. Epub 2018 Dec 4.

4.

Cardiac rehabilitation services for people in rural and remote areas: an integrative literature review.

Field PE, Franklin RC, Barker RN, Ring I, Leggat PA.

Rural Remote Health. 2018 Nov;18(4):4738. doi: 10.22605/RRH4738. Epub 2018 Nov 7. Review.

5.

Similarities and differences in surface receptor expression by THP-1 monocytes and differentiated macrophages polarized using seven different conditioning regimens.

Forrester MA, Wassall HJ, Hall LS, Cao H, Wilson HM, Barker RN, Vickers MA.

Cell Immunol. 2018 Oct;332:58-76. doi: 10.1016/j.cellimm.2018.07.008. Epub 2018 Jul 19.

PMID:
30077333
6.

Differential effects of phototherapy, adalimumab and betamethasone-calcipotriol on effector and regulatory T cells in psoriasis.

Kotb IS, Lewis BJ, Barker RN, Ormerod AD.

Br J Dermatol. 2018 Jul;179(1):127-135. doi: 10.1111/bjd.16336. Epub 2018 Apr 26.

PMID:
29330859
7.

SMART Arm Training With Outcome-Triggered Electrical Stimulation in Subacute Stroke Survivors With Severe Arm Disability: A Randomized Controlled Trial.

Barker RN, Hayward KS, Carson RG, Lloyd D, Brauer SG.

Neurorehabil Neural Repair. 2017 Dec;31(12):1005-1016. doi: 10.1177/1545968317744276. Epub 2017 Dec 4.

PMID:
29199503
8.

Community participation for individuals with spinal cord injury living in Queensland, Australia.

Carr JJ, Kendall MB, Amsters DI, Pershouse KJ, Kuipers P, Buettner P, Barker RN.

Spinal Cord. 2017 Feb;55(2):192-197. doi: 10.1038/sc.2016.169. Epub 2016 Nov 29.

PMID:
27897188
9.

Effective antigen presentation to helper T cells by human eosinophils.

Farhan RK, Vickers MA, Ghaemmaghami AM, Hall AM, Barker RN, Walsh GM.

Immunology. 2016 Dec;149(4):413-422. doi: 10.1111/imm.12658. Epub 2016 Sep 20.

10.

Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus.

Dahal LN, Basu N, Youssef H, Khanolkar RC, Barker RN, Erwig LP, Ward FJ.

Arthritis Res Ther. 2016 Aug 4;18:180. doi: 10.1186/s13075-016-1075-1.

11.

Impact of a person-centred community rehabilitation service on outcomes for individuals with a neurological condition.

Barker RN, Sealey CJ, Polley ML, Mervin MC, Comans T.

Disabil Rehabil. 2017 Jun;39(11):1136-1142. doi: 10.1080/09638288.2016.1185803. Epub 2016 Jun 9.

PMID:
27281692
12.

Intraoperative salvage does not affect expression of markers for erythrophagocytosis.

Chakravarty PD, Porter C, Cao H, Cairns L, Moss M, Duthie R, Ashcroft P, Jeffrey R, Gibson G, Buchan K, Erwig L, Barker RN, Vickers MA.

Transfus Med. 2016 Apr;26(2):147-9. doi: 10.1111/tme.12288. Epub 2016 Mar 22. No abstract available.

PMID:
27000682
13.

Electric fields are novel determinants of human macrophage functions.

Hoare JI, Rajnicek AM, McCaig CD, Barker RN, Wilson HM.

J Leukoc Biol. 2016 Jun;99(6):1141-51. doi: 10.1189/jlb.3A0815-390R. Epub 2015 Dec 30.

PMID:
26718542
14.

Self-Administered, Home-Based SMART (Sensorimotor Active Rehabilitation Training) Arm Training: A Single-Case Report.

Hayward KS, Neibling BA, Barker RN.

Am J Occup Ther. 2015 Jul-Aug;69(4):6904210020p1-8. doi: 10.5014/ajot.2015.016055.

PMID:
26114456
15.

T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid.

Pickford WJ, Gudi V, Haggart AM, Lewis BJ, Herriot R, Barker RN, Ormerod AD.

Clin Exp Immunol. 2015 May;180(2):189-200. doi: 10.1111/cei.12566.

16.

The activation status of human macrophages presenting antigen determines the efficiency of Th17 responses.

Arnold CE, Gordon P, Barker RN, Wilson HM.

Immunobiology. 2015 Jan;220(1):10-9.

17.

Targeting the alternatively spliced soluble isoform of CTLA-4: prospects for immunotherapy?

Ward FJ, Dahal LN, Khanolkar RC, Shankar SP, Barker RN.

Immunotherapy. 2014;6(10):1073-84. doi: 10.2217/imt.14.73. Review.

PMID:
25428646
18.
19.

Human interleukin-27: wide individual variation in plasma levels and complex inter-relationships with interleukin-17A.

Forrester MA, Robertson L, Bayoumi N, Keavney BD, Barker RN, Vickers MA.

Clin Exp Immunol. 2014 Nov;178(2):373-83. doi: 10.1111/cei.12408.

20.
21.

Isolation, polarization, and expansion of CD4⁺ helper T cell lines and clones using magnetic beads.

Dahal LN, Barker RN, Ward FJ.

Methods Mol Biol. 2014;1134:237-47. doi: 10.1007/978-1-4939-0326-9_18.

PMID:
24497367
22.

Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the RhD protein in HLA-transgenic mice.

Hall LS, Hall AM, Pickford W, Vickers MA, Urbaniak SJ, Barker RN.

Haematologica. 2014 Mar;99(3):588-96. doi: 10.3324/haematol.2012.082081. Epub 2014 Jan 17.

23.

Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge.

Whibley N, Maccallum DM, Vickers MA, Zafreen S, Waldmann H, Hori S, Gaffen SL, Gow NA, Barker RN, Hall AM.

Eur J Immunol. 2014 Apr;44(4):1069-83. doi: 10.1002/eji.201343604. Epub 2014 Feb 13.

24.

A critical role for suppressor of cytokine signalling 3 in promoting M1 macrophage activation and function in vitro and in vivo.

Arnold CE, Whyte CS, Gordon P, Barker RN, Rees AJ, Wilson HM.

Immunology. 2014 Jan;141(1):96-110. doi: 10.1111/imm.12173.

25.

Complex effects of vitamin E and vitamin C supplementation on in vitro neonatal mononuclear cell responses to allergens.

Wassall HJ, Devereux G, Seaton A, Barker RN.

Nutrients. 2013 Aug 26;5(9):3337-51. doi: 10.3390/nu5093337.

26.

The effect of altering a single component of a rehabilitation programme on the functional recovery of stroke patients: a systematic review and meta-analysis.

Hayward KS, Barker RN, Carson RG, Brauer SG.

Clin Rehabil. 2014 Feb;28(2):107-17. doi: 10.1177/0269215513497601. Epub 2013 Aug 6. Review.

PMID:
23922265
27.

SMART Arm with outcome-triggered electrical stimulation: a pilot randomized clinical trial.

Hayward KS, Barker RN, Brauer SG, Lloyd D, Horsley SA, Carson RG.

Top Stroke Rehabil. 2013 Jul-Aug;20(4):289-98. doi: 10.1310/tsr2004-289.

PMID:
23893828
28.

The efficacy of SMART Arm training early after stroke for stroke survivors with severe upper limb disability: a protocol for a randomised controlled trial.

Brauer SG, Hayward KS, Carson RG, Cresswell AG, Barker RN.

BMC Neurol. 2013 Jul 2;13:71. doi: 10.1186/1471-2377-13-71.

29.
30.

Predominance of activated, clonally expanded T helper type 17 cells within the CD4+ T cell population in psoriatic lesions.

Lewis BJ, Rajpara S, Haggart AM, Wilson HM, Barker RN, Ormerod AD.

Clin Exp Immunol. 2013 Jul;173(1):38-46. doi: 10.1111/cei.12086.

31.

The soluble isoform of CTLA-4 as a regulator of T-cell responses.

Ward FJ, Dahal LN, Wijesekera SK, Abdul-Jawad SK, Kaewarpai T, Xu H, Vickers MA, Barker RN.

Eur J Immunol. 2013 May;43(5):1274-85. doi: 10.1002/eji.201242529. Epub 2013 Mar 6.

32.

Extracorporeal Shock Wave Therapy (ESWT) as a treatment for recurrent Neurogenic Heterotopic Ossification (NHO).

Reznik JE, Gordon SJ, Barker RN, Keren O, Arama Y, Galea MP.

Brain Inj. 2013;27(2):242-7. doi: 10.3109/02699052.2012.729293.

PMID:
23384220
33.

Increased red cell turnover in a line of CD22-deficient mice is caused by Gpi1c: a model for hereditary haemolytic anaemia.

Walker JA, Hall AM, Kotsopoulou E, Espeli M, Nitschke L, Barker RN, Lyons PA, Smith KG.

Eur J Immunol. 2012 Dec;42(12):3212-22. doi: 10.1002/eji.201242633. Epub 2012 Oct 16.

34.

Training-induced modifications of corticospinal reactivity in severely affected stroke survivors.

Barker RN, Brauer SG, Barry BK, Gill TJ, Carson RG.

Exp Brain Res. 2012 Aug;221(2):211-21. doi: 10.1007/s00221-012-3163-z. Epub 2012 Jul 10.

PMID:
22777103
35.

Exercise to enhance mobility and prevent falls after stroke: the community stroke club randomized trial.

Dean CM, Rissel C, Sherrington C, Sharkey M, Cumming RG, Lord SR, Barker RN, Kirkham C, O'Rourke S.

Neurorehabil Neural Repair. 2012 Nov-Dec;26(9):1046-57. doi: 10.1177/1545968312441711. Epub 2012 Apr 27.

PMID:
22544817
36.

Effects of ultraviolet light on human serum 25-hydroxyvitamin D and systemic immune function.

Milliken SV, Wassall H, Lewis BJ, Logie J, Barker RN, Macdonald H, Vickers MA, Ormerod AD.

J Allergy Clin Immunol. 2012 Jun;129(6):1554-61. doi: 10.1016/j.jaci.2012.03.001. Epub 2012 Apr 12.

PMID:
22502796
37.

Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen.

Stephen J, Cairns LS, Pickford WJ, Vickers MA, Urbaniak SJ, Barker RN.

Blood. 2012 Jun 7;119(23):5563-74. doi: 10.1182/blood-2012-02-410324. Epub 2012 Apr 5.

38.

Production of the effector cytokine interleukin-17, rather than interferon-γ, is more strongly associated with autoimmune hemolytic anemia.

Hall AM, Zamzami OM, Whibley N, Hampsey DP, Haggart AM, Vickers MA, Barker RN.

Haematologica. 2012 Oct;97(10):1494-500. doi: 10.3324/haematol.2011.060822. Epub 2012 Mar 14.

39.

Investigating changes in quality of life and function along the lifespan for people with spinal cord injury.

Pershouse KJ, Barker RN, Kendall MB, Buettner PG, Kuipers P, Schuurs SB, Amsters DI.

Arch Phys Med Rehabil. 2012 Mar;93(3):413-9. doi: 10.1016/j.apmr.2011.10.014. Epub 2012 Jan 24.

PMID:
22277242
40.

Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function.

Whyte CS, Bishop ET, Rückerl D, Gaspar-Pereira S, Barker RN, Allen JE, Rees AJ, Wilson HM.

J Leukoc Biol. 2011 Nov;90(5):845-54. doi: 10.1189/jlb.1110644. Epub 2011 May 31.

PMID:
21628332
41.

Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages.

McKenzie CG, Koser U, Lewis LE, Bain JM, Mora-Montes HM, Barker RN, Gow NA, Erwig LP.

Infect Immun. 2010 Apr;78(4):1650-8. doi: 10.1128/IAI.00001-10. Epub 2010 Feb 1.

42.

Exercise intervention to prevent falls and enhance mobility in community dwellers after stroke: a protocol for a randomised controlled trial.

Dean CM, Rissel C, Sharkey M, Sherrington C, Cumming RG, Barker RN, Lord SR, O'Rourke SD, Kirkham C.

BMC Neurol. 2009 Jul 22;9:38. doi: 10.1186/1471-2377-9-38.

43.

Helper T cells point the way to specific immunotherapy for autoimmune disease.

Hall AM, Vickers MA, Barker RN, Erwig LP.

Cardiovasc Hematol Disord Drug Targets. 2009 Sep;9(3):159-66. Review.

PMID:
19534656
44.

Training-induced changes in the pattern of triceps to biceps activation during reaching tasks after chronic and severe stroke.

Barker RN, Brauer S, Carson R.

Exp Brain Res. 2009 Jul;196(4):483-96. doi: 10.1007/s00221-009-1872-8. Epub 2009 Jun 6.

PMID:
19504088
45.

Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells.

Anani Sarab G, Moss M, Barker RN, Urbaniak SJ.

Blood. 2009 Aug 27;114(9):1954-7. doi: 10.1182/blood-2009-04-211839. Epub 2009 Jun 3.

46.

Macrophages: promising targets for the treatment of atherosclerosis.

Wilson HM, Barker RN, Erwig LP.

Curr Vasc Pharmacol. 2009 Apr;7(2):234-43. Review.

PMID:
19356007
47.

Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome.

Graham A, Ford I, Morrison R, Barker RN, Greaves M, Erwig LP.

J Immunol. 2009 Feb 1;182(3):1756-62.

48.

The relationship between quality of life and disability across the lifespan for people with spinal cord injury.

Barker RN, Kendall MD, Amsters DI, Pershouse KJ, Haines TP, Kuipers P.

Spinal Cord. 2009 Feb;47(2):149-55. doi: 10.1038/sc.2008.82. Epub 2008 Jul 1.

PMID:
18594553
49.

Training of reaching in stroke survivors with severe and chronic upper limb paresis using a novel nonrobotic device: a randomized clinical trial.

Barker RN, Brauer SG, Carson RG.

Stroke. 2008 Jun;39(6):1800-7. doi: 10.1161/STROKEAHA.107.498485. Epub 2008 Apr 10.

PMID:
18403742
50.

Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma.

Mittal S, Marshall NA, Duncan L, Culligan DJ, Barker RN, Vickers MA.

Blood. 2008 Jun 1;111(11):5359-70. doi: 10.1182/blood-2007-08-105395. Epub 2008 Feb 27.

Supplemental Content

Loading ...
Support Center